Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|May 30, 2006
An efficient approach for the rapid assessment of oral rat exposures for new chemical entities in drug discoveryHyo-Kyung Han, Nalini Sadagopan, Gregory A Reichard, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Preparation of oxime dual NK(1)/NK(2) antagonists with reduced NK(3) affinityGregory A Reichard, Cheryl A Grice, Neng-Yang Shih, et al.
Organic Letters|November 7, 2003
Asymmetric synthesis of 4,4-disubstituted-2-imidazoli-dinones: potent NK1 antagonistsGregory A Reichard, Carmine Stengone, Sunil Paliwal, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2002
Structure-activity relationships of oxime neurokinin antagonists: oxime modificationsGregory A Reichard, James Spitler, Robert Aslanian, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2016
Single-Dose Primaquine in a Preclinical Model of Glucose-6-Phosphate Dehydrogenase Deficiency: Implications for Use in Malaria Transmission-Blocking ProgramsKristina S Wickham, Paul C Baresel, Sean R Marcsisin, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2006
Cyclobutane derivatives as potent NK1 selective antagonistsMichelle Laci Wrobleski, Gregory A Reichard, Sunil Paliwal, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
Synthesis and structure-activity relationships of oxime neurokinin antagonists: discovery of potent arylamidesNeng Yang Shih, Margaret Albanese, John C Anthes, et al.
Malaria Journal|June 27, 2013
CYP450 phenotyping and metabolite identification of quinine by accurate mass UPLC-MS analysis: a possible metabolic link to blackwater feverSean R Marcsisin, Xiannu Jin, Theresa Bettger, et al.
Malaria Journal|June 21, 2013
The metabolism of primaquine to its active metabolite is dependent on CYP 2D6Brandon S Pybus, Sean R Marcsisin, Xiannu Jin, et al.
Malaria Journal|August 4, 2012
CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquineBrandon S Pybus, Jason C Sousa, Xiannu Jin, et al.
Pageof 3